LOS ANGELES, June 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) said Sunday that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children aged under 5.
The analysis by FDA scientists was posted online ahead of a meeting scheduled this Wednesday for the agency's independent experts, who will consider applications from both Pfizer and Moderna on vaccinating the nation's youngest children.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
